Rocket Pharmaceuticals, Inc.
RCKT· Nasdaq
Released Nov 8, 2019, after the close
10-Q filed Nov 8, 2019, 39 days after period end · 0001140361-19-020183
No earnings release is on file for this quarter. Its figures came with the 10-Q.
| Metric | Q3 2019 | Q3 2018 | Q3 2017 | Q3 2016 |
|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $0.00 | — |
| Net Income | -$19.28M | -$16.09M | -$6.72M | -$11.13M |
| EPS Diluted | -$0.38 |
Rocket Pharmaceuticals, Inc. · CIK 1281895 · Engraved from SEC EDGAR
| -$0.40 |
| -$0.99 |
| -$0.41 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.